

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 4.84623922 |
| 2 | C4-dicarboxylate transport (GO:0015740) | 4.79313048 |
| 3 | presynaptic membrane organization (GO:0097090) | 4.26019855 |
| 4 | central nervous system myelination (GO:0022010) | 4.25622416 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 4.25622416 |
| 6 | postsynaptic membrane organization (GO:0001941) | 3.93702110 |
| 7 | fatty acid elongation (GO:0030497) | 3.71608444 |
| 8 | phenol-containing compound catabolic process (GO:0019336) | 3.69326944 |
| 9 | limb bud formation (GO:0060174) | 3.55172664 |
| 10 | nonmotile primary cilium assembly (GO:0035058) | 3.51875212 |
| 11 | oligodendrocyte differentiation (GO:0048709) | 3.39793914 |
| 12 | auditory behavior (GO:0031223) | 3.34980005 |
| 13 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.16084004 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08326727 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.08326727 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08326727 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08326727 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08326727 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.08326727 |
| 20 | mechanosensory behavior (GO:0007638) | 3.02575140 |
| 21 | cellular response to cholesterol (GO:0071397) | 3.01201725 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00365502 |
| 23 | response to nitrosative stress (GO:0051409) | 2.97025909 |
| 24 | retinal ganglion cell axon guidance (GO:0031290) | 2.95616268 |
| 25 | branched-chain amino acid catabolic process (GO:0009083) | 2.95415604 |
| 26 | neuronal action potential propagation (GO:0019227) | 2.94735305 |
| 27 | neurotransmitter uptake (GO:0001504) | 2.93982750 |
| 28 | sphingoid metabolic process (GO:0046519) | 2.91712472 |
| 29 | cholesterol biosynthetic process (GO:0006695) | 2.90979317 |
| 30 | intraciliary transport (GO:0042073) | 2.90384736 |
| 31 | sphingosine metabolic process (GO:0006670) | 2.90319011 |
| 32 | very long-chain fatty acid metabolic process (GO:0000038) | 2.89946821 |
| 33 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.86311963 |
| 34 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.85125691 |
| 35 | glial cell proliferation (GO:0014009) | 2.84722350 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79874305 |
| 37 | negative regulation of protein localization to cell surface (GO:2000009) | 2.79829475 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 2.76905559 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 2.76346271 |
| 40 | amyloid precursor protein catabolic process (GO:0042987) | 2.75697046 |
| 41 | cellular response to sterol (GO:0036315) | 2.75451080 |
| 42 | vascular smooth muscle contraction (GO:0014829) | 2.74761790 |
| 43 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.74143736 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.73019863 |
| 45 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.71087626 |
| 46 | nucleobase catabolic process (GO:0046113) | 2.70962290 |
| 47 | diol metabolic process (GO:0034311) | 2.70781897 |
| 48 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.68655672 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 2.67692991 |
| 50 | daunorubicin metabolic process (GO:0044597) | 2.67515343 |
| 51 | polyketide metabolic process (GO:0030638) | 2.67515343 |
| 52 | doxorubicin metabolic process (GO:0044598) | 2.67515343 |
| 53 | negative regulation of axon guidance (GO:1902668) | 2.66530143 |
| 54 | Notch signaling involved in heart development (GO:0061314) | 2.66341043 |
| 55 | eye photoreceptor cell differentiation (GO:0001754) | 2.62382286 |
| 56 | photoreceptor cell differentiation (GO:0046530) | 2.62382286 |
| 57 | sterol biosynthetic process (GO:0016126) | 2.61932330 |
| 58 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.61060482 |
| 59 | regulation of lipoprotein metabolic process (GO:0050746) | 2.60590136 |
| 60 | ethanol metabolic process (GO:0006067) | 2.59222655 |
| 61 | surfactant homeostasis (GO:0043129) | 2.53172665 |
| 62 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.52771190 |
| 63 | axonal fasciculation (GO:0007413) | 2.50688557 |
| 64 | response to lipoprotein particle (GO:0055094) | 2.50002283 |
| 65 | import into cell (GO:0098657) | 2.47368095 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 2.46867746 |
| 67 | ethanol oxidation (GO:0006069) | 2.46741840 |
| 68 | adhesion of symbiont to host cell (GO:0044650) | 2.45872968 |
| 69 | virion attachment to host cell (GO:0019062) | 2.45872968 |
| 70 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.45326130 |
| 71 | negative regulation of astrocyte differentiation (GO:0048712) | 2.45223812 |
| 72 | DNA double-strand break processing (GO:0000729) | 2.44772704 |
| 73 | myelin maintenance (GO:0043217) | 2.44634214 |
| 74 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.44081403 |
| 75 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.44081403 |
| 76 | thyroid hormone generation (GO:0006590) | 2.43969714 |
| 77 | fibroblast migration (GO:0010761) | 2.43560398 |
| 78 | carnitine metabolic process (GO:0009437) | 2.43095229 |
| 79 | negative regulation of protein activation cascade (GO:2000258) | 2.42027067 |
| 80 | negative chemotaxis (GO:0050919) | 2.41614986 |
| 81 | platelet dense granule organization (GO:0060155) | 2.41105322 |
| 82 | negative regulation of neurotransmitter transport (GO:0051589) | 2.40072631 |
| 83 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.38838490 |
| 84 | serine family amino acid catabolic process (GO:0009071) | 2.38827968 |
| 85 | linoleic acid metabolic process (GO:0043651) | 2.36923056 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.36718151 |
| 87 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.35544921 |
| 88 | amyloid precursor protein metabolic process (GO:0042982) | 2.35007484 |
| 89 | nephron tubule formation (GO:0072079) | 2.34802867 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.34537443 |
| 91 | response to auditory stimulus (GO:0010996) | 2.34122905 |
| 92 | membrane raft organization (GO:0031579) | 2.33484282 |
| 93 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.33466598 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 2.32645573 |
| 95 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.31940333 |
| 96 | positive regulation of chemokine secretion (GO:0090197) | 2.31270983 |
| 97 | phospholipid homeostasis (GO:0055091) | 2.30915500 |
| 98 | regulation of protein glycosylation (GO:0060049) | 2.30273228 |
| 99 | regulation of triglyceride catabolic process (GO:0010896) | 2.29022566 |
| 100 | cilium morphogenesis (GO:0060271) | 2.28529244 |
| 101 | adhesion of symbiont to host (GO:0044406) | 2.28420412 |
| 102 | cellular potassium ion homeostasis (GO:0030007) | 2.28174083 |
| 103 | positive regulation of osteoblast proliferation (GO:0033690) | 2.27885387 |
| 104 | inner ear receptor stereocilium organization (GO:0060122) | 2.27389689 |
| 105 | microglial cell activation (GO:0001774) | 2.27313656 |
| 106 | creatine metabolic process (GO:0006600) | 2.26362085 |
| 107 | phospholipid efflux (GO:0033700) | 2.26236342 |
| 108 | cilium assembly (GO:0042384) | 2.26154157 |
| 109 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.26129342 |
| 110 | cilium organization (GO:0044782) | 2.25402390 |
| 111 | primary alcohol catabolic process (GO:0034310) | 2.25064642 |
| 112 | macrophage activation involved in immune response (GO:0002281) | 2.24571602 |
| 113 | signal peptide processing (GO:0006465) | 2.24570336 |
| 114 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.24030722 |
| 115 | astrocyte differentiation (GO:0048708) | 2.23255725 |
| 116 | detection of external biotic stimulus (GO:0098581) | 2.22992480 |
| 117 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.22967913 |
| 118 | low-density lipoprotein particle remodeling (GO:0034374) | 2.22369458 |
| 119 | neuron recognition (GO:0008038) | 2.22277110 |
| 120 | replication fork processing (GO:0031297) | 2.21831564 |
| 121 | somite development (GO:0061053) | 2.21519624 |
| 122 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.21500858 |
| 123 | membrane assembly (GO:0071709) | 2.21491318 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.21317833 |
| 125 | sulfur amino acid catabolic process (GO:0000098) | 2.21231098 |
| 126 | neuron cell-cell adhesion (GO:0007158) | 2.21055472 |
| 127 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.19956251 |
| 128 | plasma lipoprotein particle assembly (GO:0034377) | 2.19895029 |
| 129 | nucleotide transmembrane transport (GO:1901679) | 2.19506894 |
| 130 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.19317857 |
| 131 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.18703106 |
| 132 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.18673487 |
| 133 | regulation of axon guidance (GO:1902667) | 2.18616657 |
| 134 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.18103503 |
| 135 | positive regulation of interferon-alpha production (GO:0032727) | 2.17726651 |
| 136 | cellular glucuronidation (GO:0052695) | 2.17621529 |
| 137 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.17520650 |
| 138 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.17306342 |
| 139 | Sertoli cell development (GO:0060009) | 2.17278866 |
| 140 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.15403022 |
| 141 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.15257194 |
| 142 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.15143684 |
| 143 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.14963929 |
| 144 | glutathione derivative metabolic process (GO:1901685) | 2.14766850 |
| 145 | glutathione derivative biosynthetic process (GO:1901687) | 2.14766850 |
| 146 | aldehyde catabolic process (GO:0046185) | 2.14390674 |
| 147 | appendage development (GO:0048736) | 2.14195247 |
| 148 | limb development (GO:0060173) | 2.14195247 |
| 149 | phagocytosis, recognition (GO:0006910) | 2.14061153 |
| 150 | regulation of neurotransmitter uptake (GO:0051580) | 2.13919539 |
| 151 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.13886995 |
| 152 | detection of other organism (GO:0098543) | 2.13746049 |
| 153 | regulation of cholesterol esterification (GO:0010872) | 2.12778028 |
| 154 | protein heterotetramerization (GO:0051290) | 2.12612424 |
| 155 | potassium ion import (GO:0010107) | 2.12462159 |
| 156 | uronic acid metabolic process (GO:0006063) | 2.11819539 |
| 157 | glucuronate metabolic process (GO:0019585) | 2.11819539 |
| 158 | astrocyte development (GO:0014002) | 2.11388101 |
| 159 | bile acid biosynthetic process (GO:0006699) | 2.10904339 |
| 160 | cranial nerve development (GO:0021545) | 2.10857294 |
| 161 | regulation of interferon-alpha production (GO:0032647) | 2.10502115 |
| 162 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.10480280 |
| 163 | positive regulation of male gonad development (GO:2000020) | 2.10325242 |
| 164 | negative regulation of lipid storage (GO:0010888) | 2.10248103 |
| 165 | cellular response to leptin stimulus (GO:0044320) | 2.10179045 |
| 166 | apoptotic cell clearance (GO:0043277) | 2.09930598 |
| 167 | cerebral cortex cell migration (GO:0021795) | 2.09917939 |
| 168 | glial cell differentiation (GO:0010001) | 2.09265289 |
| 169 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.09089652 |
| 170 | lysine metabolic process (GO:0006553) | 2.09073367 |
| 171 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.09059940 |
| 172 | regulation of heat generation (GO:0031650) | 2.08780842 |
| 173 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.08201816 |
| 174 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.07922139 |
| 175 | L-amino acid import (GO:0043092) | 2.06768902 |
| 176 | cellular response to exogenous dsRNA (GO:0071360) | 2.06661066 |
| 177 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.06216368 |
| 178 | negative regulation of lipase activity (GO:0060192) | 2.05690651 |
| 179 | purine nucleotide transport (GO:0015865) | 2.04890681 |
| 180 | desmosome organization (GO:0002934) | 2.04483908 |
| 181 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.04303488 |
| 182 | response to host immune response (GO:0052572) | 2.04070645 |
| 183 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.04070645 |
| 184 | response to muramyl dipeptide (GO:0032495) | 2.03927321 |
| 185 | neutrophil activation (GO:0042119) | 2.03740394 |
| 186 | hormone catabolic process (GO:0042447) | 2.03708250 |
| 187 | thioester biosynthetic process (GO:0035384) | 2.02695686 |
| 188 | acyl-CoA biosynthetic process (GO:0071616) | 2.02695686 |
| 189 | reverse cholesterol transport (GO:0043691) | 2.01990582 |
| 190 | response to methylmercury (GO:0051597) | 2.01336076 |
| 191 | purine ribonucleotide transport (GO:0015868) | 2.00982976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.65647143 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.51847358 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47364705 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.44670029 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.18813071 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03557225 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.93502917 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.92668429 |
| 9 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79355545 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.76479148 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.64920266 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60645911 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48567711 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41145795 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.36561821 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35708034 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35329147 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.34840334 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.33052991 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25596533 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25305677 |
| 22 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.24315457 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22340304 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.19351098 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.17462904 |
| 26 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.17414259 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.16511642 |
| 28 | P300_19829295_ChIP-Seq_ESCs_Human | 2.15552861 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.13942176 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13699619 |
| 31 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13409705 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.03807844 |
| 33 | EWS_26573619_Chip-Seq_HEK293_Human | 2.03428924 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.00059865 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97120661 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.93842839 |
| 37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93760390 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92121012 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.90832211 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89092621 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.88743673 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.88661577 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.87245058 |
| 44 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87203014 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85778743 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82894542 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.82578986 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77785777 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75502386 |
| 50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73543912 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.73054587 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69797841 |
| 53 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.65689893 |
| 54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65131427 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64823049 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.63248984 |
| 57 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61818734 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.60643364 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60499201 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58719685 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58471441 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57549454 |
| 63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56700949 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52470618 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50778600 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49979890 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48006456 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47368728 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.46278575 |
| 70 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.45968002 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45908439 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.45890207 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44161904 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43682510 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43396290 |
| 76 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.43333460 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.42941182 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42158704 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41828251 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41638307 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41590470 |
| 82 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.41270815 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41097017 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41046305 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40509858 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39531868 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39453568 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37162317 |
| 89 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.36526660 |
| 90 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.35105490 |
| 91 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34670464 |
| 92 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.33871369 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32013672 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31917904 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31917018 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29930101 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29930101 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.28927616 |
| 99 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28823986 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28334417 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27967797 |
| 102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26752438 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.25768592 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25459034 |
| 105 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25033026 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24102577 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23180614 |
| 108 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22227701 |
| 109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22040172 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21989185 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21797458 |
| 112 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21492904 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21433159 |
| 114 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21145189 |
| 115 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21145189 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19834162 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18869914 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18223145 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17839500 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17839500 |
| 121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.17618975 |
| 122 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.17555574 |
| 123 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17469449 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16617858 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16241095 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14545901 |
| 127 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12626391 |
| 128 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12603790 |
| 129 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12385179 |
| 130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11867943 |
| 131 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10338095 |
| 132 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10204519 |
| 133 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10056839 |
| 134 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10056839 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09529303 |
| 136 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09372382 |
| 137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08864972 |
| 138 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.08752949 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08733047 |
| 140 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.08650983 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07810830 |
| 142 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07450117 |
| 143 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07223879 |
| 144 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07071221 |
| 145 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06299623 |
| 146 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.06133532 |
| 147 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06045497 |
| 148 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05610818 |
| 149 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05432709 |
| 150 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05248736 |
| 151 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04704378 |
| 152 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.04683990 |
| 153 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.04347617 |
| 154 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04138358 |
| 155 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03405477 |
| 156 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02595209 |
| 157 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02321729 |
| 158 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01747233 |
| 159 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01586676 |
| 160 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00682686 |
| 161 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98916647 |
| 162 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98541568 |
| 163 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98384492 |
| 164 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97296352 |
| 165 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96283980 |
| 166 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96283980 |
| 167 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.96024607 |
| 168 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95079969 |
| 169 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94760234 |
| 170 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94576260 |
| 171 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94159150 |
| 172 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93889532 |
| 173 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92621978 |
| 174 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92291389 |
| 175 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.92128693 |
| 176 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89684038 |
| 177 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89423596 |
| 178 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89243619 |
| 179 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87966956 |
| 180 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86884209 |
| 181 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85376119 |
| 182 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85083795 |
| 183 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84358870 |
| 184 | MYB_26560356_Chip-Seq_TH2_Human | 0.84291573 |
| 185 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83803425 |
| 186 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.79776729 |
| 187 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.78774330 |
| 188 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78428663 |
| 189 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77747043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 3.30013870 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 3.06620777 |
| 3 | MP0003880_abnormal_central_pattern | 3.04839292 |
| 4 | MP0003724_increased_susceptibility_to | 2.75787778 |
| 5 | MP0008004_abnormal_stomach_pH | 2.72893610 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.56094489 |
| 7 | MP0002736_abnormal_nociception_after | 2.51595229 |
| 8 | MP0003690_abnormal_glial_cell | 2.40086318 |
| 9 | MP0009840_abnormal_foam_cell | 2.38881990 |
| 10 | MP0003136_yellow_coat_color | 2.34759910 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.26586293 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.16296839 |
| 13 | MP0001984_abnormal_olfaction | 2.11045546 |
| 14 | MP0002234_abnormal_pharynx_morphology | 2.09125764 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.05693948 |
| 16 | MP0004147_increased_porphyrin_level | 2.00883193 |
| 17 | MP0003656_abnormal_erythrocyte_physiolo | 2.00733631 |
| 18 | MP0003122_maternal_imprinting | 1.99667176 |
| 19 | MP0002938_white_spotting | 1.98916469 |
| 20 | MP0000920_abnormal_myelination | 1.98465339 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 1.98028984 |
| 22 | MP0005253_abnormal_eye_physiology | 1.92346236 |
| 23 | MP0003868_abnormal_feces_composition | 1.91861402 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 1.90426574 |
| 25 | MP0000778_abnormal_nervous_system | 1.89703937 |
| 26 | MP0005248_abnormal_Harderian_gland | 1.82949680 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.82262239 |
| 28 | MP0005365_abnormal_bile_salt | 1.82099793 |
| 29 | * MP0002419_abnormal_innate_immunity | 1.79061036 |
| 30 | MP0002233_abnormal_nose_morphology | 1.73232032 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.73158815 |
| 32 | MP0003436_decreased_susceptibility_to | 1.72112760 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.68583151 |
| 34 | MP0000516_abnormal_urinary_system | 1.67631348 |
| 35 | MP0005367_renal/urinary_system_phenotyp | 1.67631348 |
| 36 | MP0002796_impaired_skin_barrier | 1.66821485 |
| 37 | MP0001529_abnormal_vocalization | 1.66223873 |
| 38 | MP0002254_reproductive_system_inflammat | 1.66075570 |
| 39 | MP0001486_abnormal_startle_reflex | 1.65642404 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.64510123 |
| 41 | MP0008789_abnormal_olfactory_epithelium | 1.64169280 |
| 42 | MP0009785_altered_susceptibility_to | 1.63835829 |
| 43 | MP0001790_abnormal_immune_system | 1.62453610 |
| 44 | MP0005387_immune_system_phenotype | 1.62453610 |
| 45 | MP0005025_abnormal_response_to | 1.61938782 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.59189129 |
| 47 | MP0005360_urolithiasis | 1.58370152 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.58337686 |
| 49 | MP0005085_abnormal_gallbladder_physiolo | 1.54867307 |
| 50 | MP0004381_abnormal_hair_follicle | 1.54241360 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.52486631 |
| 52 | MP0000566_synostosis | 1.52426796 |
| 53 | MP0009764_decreased_sensitivity_to | 1.51724078 |
| 54 | MP0003195_calcinosis | 1.51359466 |
| 55 | MP0000685_abnormal_immune_system | 1.51083614 |
| 56 | MP0000383_abnormal_hair_follicle | 1.51037850 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.49273101 |
| 58 | MP0006082_CNS_inflammation | 1.48548586 |
| 59 | * MP0003186_abnormal_redox_activity | 1.48338326 |
| 60 | MP0002282_abnormal_trachea_morphology | 1.47623770 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.46345090 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.46140246 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.45888243 |
| 64 | MP0001853_heart_inflammation | 1.45240608 |
| 65 | MP0001666_abnormal_nutrient_absorption | 1.44994662 |
| 66 | MP0001873_stomach_inflammation | 1.43953208 |
| 67 | MP0004272_abnormal_basement_membrane | 1.41954339 |
| 68 | MP0005000_abnormal_immune_tolerance | 1.41273080 |
| 69 | MP0003755_abnormal_palate_morphology | 1.39828379 |
| 70 | MP0005671_abnormal_response_to | 1.38136844 |
| 71 | MP0003303_peritoneal_inflammation | 1.38002787 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.36196003 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.35356014 |
| 74 | MP0003075_altered_response_to | 1.33826246 |
| 75 | MP0003011_delayed_dark_adaptation | 1.33602740 |
| 76 | MP0003937_abnormal_limbs/digits/tail_de | 1.33424148 |
| 77 | MP0000343_altered_response_to | 1.33296315 |
| 78 | MP0004947_skin_inflammation | 1.32118363 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 1.31941641 |
| 80 | MP0001958_emphysema | 1.30678996 |
| 81 | MP0005423_abnormal_somatic_nervous | 1.30330667 |
| 82 | MP0010678_abnormal_skin_adnexa | 1.30194744 |
| 83 | MP0005187_abnormal_penis_morphology | 1.30079186 |
| 84 | MP0001293_anophthalmia | 1.28378221 |
| 85 | MP0004885_abnormal_endolymph | 1.27822060 |
| 86 | MP0005391_vision/eye_phenotype | 1.27013898 |
| 87 | MP0002751_abnormal_autonomic_nervous | 1.26594498 |
| 88 | MP0009384_cardiac_valve_regurgitation | 1.26416733 |
| 89 | MP0002098_abnormal_vibrissa_morphology | 1.25844543 |
| 90 | MP0002090_abnormal_vision | 1.25550790 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 1.25441966 |
| 92 | * MP0002452_abnormal_antigen_presenting | 1.25255103 |
| 93 | MP0010155_abnormal_intestine_physiology | 1.23422876 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 1.23416926 |
| 95 | MP0002723_abnormal_immune_serum | 1.22793660 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 1.22039306 |
| 97 | MP0003121_genomic_imprinting | 1.21285245 |
| 98 | MP0003252_abnormal_bile_duct | 1.20798465 |
| 99 | MP0004859_abnormal_synaptic_plasticity | 1.19493153 |
| 100 | MP0002166_altered_tumor_susceptibility | 1.17685380 |
| 101 | MP0005451_abnormal_body_composition | 1.17072560 |
| 102 | MP0002132_abnormal_respiratory_system | 1.16904917 |
| 103 | MP0004270_analgesia | 1.16701268 |
| 104 | * MP0008469_abnormal_protein_level | 1.16659331 |
| 105 | MP0001800_abnormal_humoral_immune | 1.13286499 |
| 106 | MP0005083_abnormal_biliary_tract | 1.13259139 |
| 107 | MP0006054_spinal_hemorrhage | 1.12568471 |
| 108 | MP0000569_abnormal_digit_pigmentation | 1.12057855 |
| 109 | * MP0010329_abnormal_lipoprotein_level | 1.11907333 |
| 110 | MP0002557_abnormal_social/conspecific_i | 1.11720867 |
| 111 | MP0005499_abnormal_olfactory_system | 1.11504949 |
| 112 | MP0005394_taste/olfaction_phenotype | 1.11504949 |
| 113 | MP0000026_abnormal_inner_ear | 1.08796000 |
| 114 | MP0005165_increased_susceptibility_to | 1.08004426 |
| 115 | MP0001851_eye_inflammation | 1.07580516 |
| 116 | MP0001845_abnormal_inflammatory_respons | 1.07210089 |
| 117 | MP0005164_abnormal_response_to | 1.07191233 |
| 118 | MP0006276_abnormal_autonomic_nervous | 1.05161134 |
| 119 | * MP0002118_abnormal_lipid_homeostasis | 1.04660766 |
| 120 | * MP0002420_abnormal_adaptive_immunity | 1.04278855 |
| 121 | MP0003828_pulmonary_edema | 1.04148948 |
| 122 | MP0008438_abnormal_cutaneous_collagen | 1.04048436 |
| 123 | * MP0001819_abnormal_immune_cell | 1.03953978 |
| 124 | MP0001177_atelectasis | 1.03270310 |
| 125 | MP0005195_abnormal_posterior_eye | 1.02577049 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 1.02311300 |
| 127 | MP0002272_abnormal_nervous_system | 1.02015414 |
| 128 | MP0000647_abnormal_sebaceous_gland | 0.98931660 |
| 129 | MP0002734_abnormal_mechanical_nocicepti | 0.98862379 |
| 130 | MP0005332_abnormal_amino_acid | 0.98419094 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.98237047 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.98057574 |
| 133 | MP0009697_abnormal_copulation | 0.96084026 |
| 134 | MP0005166_decreased_susceptibility_to | 0.95985614 |
| 135 | MP0005501_abnormal_skin_physiology | 0.95266645 |
| 136 | MP0003279_aneurysm | 0.94382572 |
| 137 | MP0000955_abnormal_spinal_cord | 0.93706764 |
| 138 | MP0002697_abnormal_eye_size | 0.93531757 |
| 139 | MP0001346_abnormal_lacrimal_gland | 0.93339182 |
| 140 | MP0002006_tumorigenesis | 0.92830114 |
| 141 | MP0002060_abnormal_skin_morphology | 0.92746560 |
| 142 | MP0002277_abnormal_respiratory_mucosa | 0.92629996 |
| 143 | MP0001216_abnormal_epidermal_layer | 0.92606959 |
| 144 | MP0000049_abnormal_middle_ear | 0.92384578 |
| 145 | MP0005275_abnormal_skin_tensile | 0.91675199 |
| 146 | MP0002102_abnormal_ear_morphology | 0.91251168 |
| 147 | MP0001324_abnormal_eye_pigmentation | 0.91066991 |
| 148 | MP0005408_hypopigmentation | 0.90833337 |
| 149 | MP0001963_abnormal_hearing_physiology | 0.90674088 |
| 150 | MP0004185_abnormal_adipocyte_glucose | 0.90434262 |
| 151 | MP0000609_abnormal_liver_physiology | 0.90371421 |
| 152 | MP0000427_abnormal_hair_cycle | 0.89368810 |
| 153 | MP0009763_increased_sensitivity_to | 0.89128635 |
| 154 | MP0003878_abnormal_ear_physiology | 0.88934395 |
| 155 | MP0005377_hearing/vestibular/ear_phenot | 0.88934395 |
| 156 | MP0001764_abnormal_homeostasis | 0.88856252 |
| 157 | MP0000631_abnormal_neuroendocrine_gland | 0.88262763 |
| 158 | MP0000604_amyloidosis | 0.88169108 |
| 159 | MP0001286_abnormal_eye_development | 0.87934091 |
| 160 | MP0004133_heterotaxia | 0.87301159 |
| 161 | MP0002933_joint_inflammation | 0.87152410 |
| 162 | MP0010368_abnormal_lymphatic_system | 0.86912784 |
| 163 | MP0000534_abnormal_ureter_morphology | 0.85967015 |
| 164 | MP0003566_abnormal_cell_adhesion | 0.85888230 |
| 165 | MP0009053_abnormal_anal_canal | 0.85303922 |
| 166 | MP0000372_irregular_coat_pigmentation | 0.85275364 |
| 167 | MP0009643_abnormal_urine_homeostasis | 0.85047092 |
| 168 | MP0002752_abnormal_somatic_nervous | 0.85005759 |
| 169 | MP0002572_abnormal_emotion/affect_behav | 0.83675320 |
| 170 | MP0010030_abnormal_orbit_morphology | 0.83658404 |
| 171 | MP0003935_abnormal_craniofacial_develop | 0.81282214 |
| 172 | MP0009745_abnormal_behavioral_response | 0.80885558 |
| 173 | MP0002092_abnormal_eye_morphology | 0.80108385 |
| 174 | MP0003385_abnormal_body_wall | 0.79910684 |
| 175 | MP0000538_abnormal_urinary_bladder | 0.78883445 |
| 176 | MP0003942_abnormal_urinary_system | 0.78007232 |
| 177 | MP0002067_abnormal_sensory_capabilities | 0.77561825 |
| 178 | MP0004215_abnormal_myocardial_fiber | 0.76520763 |
| 179 | MP0003633_abnormal_nervous_system | 0.76175182 |
| 180 | MP0002064_seizures | 0.76056483 |
| 181 | MP0001485_abnormal_pinna_reflex | 0.75444681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 4.20115671 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 3.70905593 |
| 3 | Hemiparesis (HP:0001269) | 3.43851339 |
| 4 | True hermaphroditism (HP:0010459) | 3.43359720 |
| 5 | Onycholysis (HP:0001806) | 3.41386357 |
| 6 | Hyperglycinemia (HP:0002154) | 3.34709075 |
| 7 | Axonal loss (HP:0003447) | 3.25687400 |
| 8 | Medial flaring of the eyebrow (HP:0010747) | 3.15030824 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.10588845 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.08013892 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.03884578 |
| 12 | Gait imbalance (HP:0002141) | 3.01003494 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 2.99714463 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.95885333 |
| 15 | Congenital primary aphakia (HP:0007707) | 2.94853507 |
| 16 | Intestinal atresia (HP:0011100) | 2.93970047 |
| 17 | Abnormality of macrophages (HP:0004311) | 2.87781037 |
| 18 | Neurofibrillary tangles (HP:0002185) | 2.85194699 |
| 19 | Chronic otitis media (HP:0000389) | 2.83371513 |
| 20 | Genital tract atresia (HP:0001827) | 2.80519174 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 2.80250623 |
| 22 | Dysostosis multiplex (HP:0000943) | 2.79356768 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 2.77499892 |
| 24 | Vascular calcification (HP:0004934) | 2.77423219 |
| 25 | Pancreatic fibrosis (HP:0100732) | 2.73102634 |
| 26 | Vaginal atresia (HP:0000148) | 2.69536831 |
| 27 | Bifid tongue (HP:0010297) | 2.67478643 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66121187 |
| 29 | Amyloidosis (HP:0011034) | 2.65081011 |
| 30 | Hepatosplenomegaly (HP:0001433) | 2.63598727 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 2.63188137 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.63188137 |
| 33 | Hyperglycinuria (HP:0003108) | 2.62106657 |
| 34 | Hyperlipoproteinemia (HP:0010980) | 2.58477240 |
| 35 | Intrahepatic cholestasis (HP:0001406) | 2.57768210 |
| 36 | Xanthomatosis (HP:0000991) | 2.57766480 |
| 37 | Renal hypoplasia (HP:0000089) | 2.56979812 |
| 38 | Abnormality of secondary sexual hair (HP:0009888) | 2.56777038 |
| 39 | Abnormality of the axillary hair (HP:0100134) | 2.56777038 |
| 40 | Postaxial hand polydactyly (HP:0001162) | 2.53724972 |
| 41 | Nephrogenic diabetes insipidus (HP:0009806) | 2.51452950 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.51290954 |
| 43 | Pancreatic cysts (HP:0001737) | 2.49522565 |
| 44 | Myocardial infarction (HP:0001658) | 2.45617968 |
| 45 | Prolonged partial thromboplastin time (HP:0003645) | 2.42837516 |
| 46 | Purpura (HP:0000979) | 2.42703670 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.40859840 |
| 48 | Hypobetalipoproteinemia (HP:0003563) | 2.40585111 |
| 49 | Abnormality of midbrain morphology (HP:0002418) | 2.40270843 |
| 50 | Molar tooth sign on MRI (HP:0002419) | 2.40270843 |
| 51 | Urticaria (HP:0001025) | 2.40107298 |
| 52 | Occipital encephalocele (HP:0002085) | 2.35320708 |
| 53 | Broad foot (HP:0001769) | 2.34615041 |
| 54 | Loss of speech (HP:0002371) | 2.34506532 |
| 55 | Clumsiness (HP:0002312) | 2.33450556 |
| 56 | Recurrent skin infections (HP:0001581) | 2.32840955 |
| 57 | Vitreoretinal degeneration (HP:0000655) | 2.30008175 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.28585613 |
| 59 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.27430999 |
| 60 | Increased corneal curvature (HP:0100692) | 2.25816550 |
| 61 | Keratoconus (HP:0000563) | 2.25816550 |
| 62 | Focal motor seizures (HP:0011153) | 2.24070208 |
| 63 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.23466660 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.23010296 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.23010296 |
| 66 | Gingival bleeding (HP:0000225) | 2.22762698 |
| 67 | Joint hemorrhage (HP:0005261) | 2.22310251 |
| 68 | Petechiae (HP:0000967) | 2.22193104 |
| 69 | Pustule (HP:0200039) | 2.19236100 |
| 70 | Postaxial foot polydactyly (HP:0001830) | 2.18523561 |
| 71 | Hypolipoproteinemia (HP:0010981) | 2.16616345 |
| 72 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.14948598 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13683187 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13683187 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13683187 |
| 76 | Cutaneous finger syndactyly (HP:0010554) | 2.12852969 |
| 77 | Patchy hypopigmentation of hair (HP:0011365) | 2.12593095 |
| 78 | Ileus (HP:0002595) | 2.10853065 |
| 79 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.10575169 |
| 80 | Gastrointestinal atresia (HP:0002589) | 2.08342010 |
| 81 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.07665727 |
| 82 | Short tibia (HP:0005736) | 2.07502193 |
| 83 | Tetraparesis (HP:0002273) | 2.06914648 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.05326812 |
| 85 | Complement deficiency (HP:0004431) | 2.05196720 |
| 86 | White forelock (HP:0002211) | 2.03842978 |
| 87 | Nephronophthisis (HP:0000090) | 2.03092603 |
| 88 | Astrocytoma (HP:0009592) | 2.02963222 |
| 89 | Abnormality of the astrocytes (HP:0100707) | 2.02963222 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.02132195 |
| 91 | Chorioretinal atrophy (HP:0000533) | 1.99274959 |
| 92 | Stomatitis (HP:0010280) | 1.99090756 |
| 93 | Hemiplegia (HP:0002301) | 1.98921765 |
| 94 | Abnormality of serum amino acid levels (HP:0003112) | 1.98463363 |
| 95 | Anophthalmia (HP:0000528) | 1.98113116 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.97768922 |
| 97 | Megalencephaly (HP:0001355) | 1.97626821 |
| 98 | Thick nail (HP:0001805) | 1.97246576 |
| 99 | Median cleft lip (HP:0000161) | 1.96672741 |
| 100 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.96288449 |
| 101 | Spastic paraparesis (HP:0002313) | 1.96110208 |
| 102 | Plantar hyperkeratosis (HP:0007556) | 1.95581825 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 1.95266668 |
| 104 | Hydroxyprolinuria (HP:0003080) | 1.95228605 |
| 105 | Abnormality of proline metabolism (HP:0010907) | 1.95228605 |
| 106 | Esophageal varix (HP:0002040) | 1.93795652 |
| 107 | Supernumerary spleens (HP:0009799) | 1.93708965 |
| 108 | Increased serum ferritin (HP:0003281) | 1.93431829 |
| 109 | Split foot (HP:0001839) | 1.92094252 |
| 110 | Glomerulonephritis (HP:0000099) | 1.91283674 |
| 111 | Abnormality of the renal medulla (HP:0100957) | 1.91015998 |
| 112 | Oligodactyly (hands) (HP:0001180) | 1.90951981 |
| 113 | Epistaxis (HP:0000421) | 1.88997021 |
| 114 | Poor coordination (HP:0002370) | 1.88305374 |
| 115 | Chronic hepatic failure (HP:0100626) | 1.88264841 |
| 116 | Prolonged bleeding time (HP:0003010) | 1.87278793 |
| 117 | Myositis (HP:0100614) | 1.86037653 |
| 118 | Spontaneous hematomas (HP:0007420) | 1.84353502 |
| 119 | Osteolytic defects of the hand bones (HP:0009699) | 1.82523693 |
| 120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82523693 |
| 121 | Neonatal short-limb short stature (HP:0008921) | 1.82361149 |
| 122 | Glioma (HP:0009733) | 1.82173350 |
| 123 | Abnormality of the ischium (HP:0003174) | 1.81770061 |
| 124 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81285434 |
| 125 | Acanthocytosis (HP:0001927) | 1.79836171 |
| 126 | Preaxial hand polydactyly (HP:0001177) | 1.79366396 |
| 127 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79265086 |
| 128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79265086 |
| 129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79265086 |
| 130 | Hyperammonemia (HP:0001987) | 1.79243537 |
| 131 | Papillary thyroid carcinoma (HP:0002895) | 1.79155795 |
| 132 | Cystic liver disease (HP:0006706) | 1.78742178 |
| 133 | Premature skin wrinkling (HP:0100678) | 1.78733534 |
| 134 | Menorrhagia (HP:0000132) | 1.78186403 |
| 135 | Volvulus (HP:0002580) | 1.77750217 |
| 136 | Erythroderma (HP:0001019) | 1.77720768 |
| 137 | Hypoalphalipoproteinemia (HP:0003233) | 1.77394631 |
| 138 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.77345048 |
| 139 | Renal cortical cysts (HP:0000803) | 1.76978122 |
| 140 | Fat malabsorption (HP:0002630) | 1.76718020 |
| 141 | Hyperventilation (HP:0002883) | 1.76407185 |
| 142 | Steatorrhea (HP:0002570) | 1.75237443 |
| 143 | Deep venous thrombosis (HP:0002625) | 1.75186100 |
| 144 | Hepatoblastoma (HP:0002884) | 1.75145018 |
| 145 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.75114823 |
| 146 | Ectropion (HP:0000656) | 1.74957417 |
| 147 | Coronal craniosynostosis (HP:0004440) | 1.74765403 |
| 148 | Specific learning disability (HP:0001328) | 1.74671257 |
| 149 | Orchitis (HP:0100796) | 1.74671136 |
| 150 | Polycythemia (HP:0001901) | 1.74605620 |
| 151 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.74243081 |
| 152 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73505098 |
| 153 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.72373424 |
| 154 | Inflammation of the large intestine (HP:0002037) | 1.72156021 |
| 155 | Vasculitis (HP:0002633) | 1.71865595 |
| 156 | Synostosis involving the elbow (HP:0003938) | 1.70505217 |
| 157 | Humeroradial synostosis (HP:0003041) | 1.70505217 |
| 158 | Epidermoid cyst (HP:0200040) | 1.70308838 |
| 159 | Abnormality of glycolysis (HP:0004366) | 1.69802702 |
| 160 | Action tremor (HP:0002345) | 1.69466753 |
| 161 | Chronic diarrhea (HP:0002028) | 1.69311890 |
| 162 | Pulmonary embolism (HP:0002204) | 1.69285374 |
| 163 | Congenital sensorineural hearing impairment (HP:0008527) | 1.68831757 |
| 164 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.68720856 |
| 165 | Palmoplantar hyperkeratosis (HP:0000972) | 1.68642452 |
| 166 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.68224513 |
| 167 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.67973708 |
| 168 | Neonatal respiratory distress (HP:0002643) | 1.67842814 |
| 169 | Erythema (HP:0010783) | 1.67654235 |
| 170 | Tubulointerstitial nephritis (HP:0001970) | 1.67407734 |
| 171 | Cerebellar dysplasia (HP:0007033) | 1.67079008 |
| 172 | Retinal atrophy (HP:0001105) | 1.66869843 |
| 173 | Right ventricular cardiomyopathy (HP:0011663) | 1.66272140 |
| 174 | Abnormality of complement system (HP:0005339) | 1.65866304 |
| 175 | Sclerocornea (HP:0000647) | 1.65797446 |
| 176 | Abnormality of the lumbar spine (HP:0100712) | 1.65791294 |
| 177 | Congenital, generalized hypertrichosis (HP:0004540) | 1.64811601 |
| 178 | Male pseudohermaphroditism (HP:0000037) | 1.64736540 |
| 179 | Cutaneous syndactyly (HP:0012725) | 1.63913395 |
| 180 | Sensorimotor neuropathy (HP:0007141) | 1.62496548 |
| 181 | Aganglionic megacolon (HP:0002251) | 1.60563965 |
| 182 | Congenital hepatic fibrosis (HP:0002612) | 1.60237035 |
| 183 | Pheochromocytoma (HP:0002666) | 1.60044910 |
| 184 | Blue irides (HP:0000635) | 1.59679558 |
| 185 | Increased serum pyruvate (HP:0003542) | 1.57791505 |
| 186 | Fibular hypoplasia (HP:0003038) | 1.57474301 |
| 187 | Large for gestational age (HP:0001520) | 1.57452012 |
| 188 | Abnormality of the renal cortex (HP:0011035) | 1.57383198 |
| 189 | Alacrima (HP:0000522) | 1.57357619 |
| 190 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.56031455 |
| 191 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.55964242 |
| 192 | Astigmatism (HP:0000483) | 1.55836104 |
| 193 | Decreased testicular size (HP:0008734) | 1.55723362 |
| 194 | Preaxial foot polydactyly (HP:0001841) | 1.55246722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.85283794 |
| 2 | EPHB1 | 2.85667459 |
| 3 | EPHA4 | 2.80351404 |
| 4 | MST4 | 2.76654876 |
| 5 | PBK | 2.54885257 |
| 6 | IRAK3 | 2.28010915 |
| 7 | TGFBR2 | 2.26651465 |
| 8 | MAP4K2 | 2.17144685 |
| 9 | STK39 | 2.05552740 |
| 10 | ERN1 | 1.98150090 |
| 11 | WEE1 | 1.96990983 |
| 12 | ERBB3 | 1.96156608 |
| 13 | MARK1 | 1.94990548 |
| 14 | WNK3 | 1.94904829 |
| 15 | MST1R | 1.94150201 |
| 16 | PLK2 | 1.89630936 |
| 17 | MAPKAPK5 | 1.89620459 |
| 18 | MAP3K14 | 1.87809928 |
| 19 | BLK | 1.85959446 |
| 20 | MKNK2 | 1.84157137 |
| 21 | PNCK | 1.84124416 |
| 22 | TAOK3 | 1.83808751 |
| 23 | TRIM28 | 1.82877191 |
| 24 | TBK1 | 1.82331695 |
| 25 | NTRK3 | 1.80742551 |
| 26 | MAP4K1 | 1.79591743 |
| 27 | MAPK13 | 1.78144479 |
| 28 | TYK2 | 1.75210673 |
| 29 | TIE1 | 1.74645071 |
| 30 | SIK1 | 1.64068915 |
| 31 | MKNK1 | 1.58730937 |
| 32 | MUSK | 1.56502112 |
| 33 | IRAK4 | 1.55232747 |
| 34 | STK38L | 1.52394052 |
| 35 | LMTK2 | 1.51225654 |
| 36 | TRPM7 | 1.50102285 |
| 37 | PDK2 | 1.49943740 |
| 38 | TRIB3 | 1.49842731 |
| 39 | KDR | 1.48751720 |
| 40 | CSNK1G2 | 1.47706435 |
| 41 | IKBKE | 1.46713821 |
| 42 | CSNK1G1 | 1.45620619 |
| 43 | TXK | 1.44609419 |
| 44 | STK10 | 1.44574919 |
| 45 | IKBKB | 1.43871713 |
| 46 | CSNK1G3 | 1.40638382 |
| 47 | FER | 1.39861802 |
| 48 | NTRK2 | 1.38118281 |
| 49 | KIT | 1.36963436 |
| 50 | TEC | 1.34601566 |
| 51 | CSNK1A1L | 1.33994260 |
| 52 | NEK9 | 1.31380575 |
| 53 | TNIK | 1.30297492 |
| 54 | LRRK2 | 1.30046351 |
| 55 | NEK1 | 1.28494593 |
| 56 | EIF2AK3 | 1.27118749 |
| 57 | JAK3 | 1.26955024 |
| 58 | PAK6 | 1.25917929 |
| 59 | PINK1 | 1.24952594 |
| 60 | PAK3 | 1.23072757 |
| 61 | INSRR | 1.22093983 |
| 62 | JAK1 | 1.20869135 |
| 63 | CDK19 | 1.19911923 |
| 64 | PRKD3 | 1.17346871 |
| 65 | NLK | 1.16671517 |
| 66 | NUAK1 | 1.14997573 |
| 67 | IRAK1 | 1.11647888 |
| 68 | PKN1 | 1.11340620 |
| 69 | EIF2AK1 | 1.10062609 |
| 70 | NTRK1 | 1.09063477 |
| 71 | ACVR1B | 1.07508768 |
| 72 | BRSK2 | 1.07424858 |
| 73 | ZAP70 | 1.07398413 |
| 74 | MET | 1.06842527 |
| 75 | SRPK1 | 1.05811019 |
| 76 | PIK3CG | 1.03163571 |
| 77 | DMPK | 1.02418593 |
| 78 | GRK1 | 1.02377841 |
| 79 | NME2 | 1.01636080 |
| 80 | PIM2 | 1.01275902 |
| 81 | MAP2K2 | 0.99356667 |
| 82 | BTK | 0.99240642 |
| 83 | ITK | 0.97787176 |
| 84 | PRKCQ | 0.95152003 |
| 85 | PLK3 | 0.93976094 |
| 86 | MAP3K4 | 0.93759966 |
| 87 | ROCK1 | 0.93595910 |
| 88 | MAP3K13 | 0.89814592 |
| 89 | ROCK2 | 0.88898297 |
| 90 | OXSR1 | 0.88364360 |
| 91 | CSK | 0.87256802 |
| 92 | KSR1 | 0.85396678 |
| 93 | MAP2K3 | 0.83723254 |
| 94 | WNK4 | 0.83316822 |
| 95 | PRKCG | 0.82139095 |
| 96 | BCKDK | 0.78059672 |
| 97 | CAMK1D | 0.77456356 |
| 98 | CSF1R | 0.76226021 |
| 99 | MAPK15 | 0.75221542 |
| 100 | ABL2 | 0.74694693 |
| 101 | JAK2 | 0.74486142 |
| 102 | MAPK12 | 0.74135134 |
| 103 | DYRK2 | 0.73707038 |
| 104 | PIK3CA | 0.73143977 |
| 105 | PRKG2 | 0.73029043 |
| 106 | FGFR1 | 0.72990023 |
| 107 | TGFBR1 | 0.72173522 |
| 108 | ERBB2 | 0.72000465 |
| 109 | PTK6 | 0.71986861 |
| 110 | LYN | 0.71122344 |
| 111 | RIPK4 | 0.70544169 |
| 112 | ERBB4 | 0.67781995 |
| 113 | CAMK2D | 0.67586158 |
| 114 | FGFR2 | 0.66011065 |
| 115 | PRKAA2 | 0.65366399 |
| 116 | PHKG2 | 0.64424840 |
| 117 | PHKG1 | 0.64424840 |
| 118 | EPHA3 | 0.64241456 |
| 119 | LCK | 0.64021197 |
| 120 | BRSK1 | 0.63759585 |
| 121 | EPHB2 | 0.63744268 |
| 122 | FGFR4 | 0.62899608 |
| 123 | PRKD1 | 0.62764308 |
| 124 | MYLK | 0.62434849 |
| 125 | GRK7 | 0.61924693 |
| 126 | CCNB1 | 0.59541594 |
| 127 | BMPR1B | 0.59332304 |
| 128 | RAF1 | 0.58441169 |
| 129 | CAMK2G | 0.58329264 |
| 130 | MAP2K6 | 0.57672470 |
| 131 | ADRBK2 | 0.55521058 |
| 132 | DYRK3 | 0.54565330 |
| 133 | MAP2K7 | 0.54240925 |
| 134 | NEK6 | 0.53962583 |
| 135 | CAMK2A | 0.53805231 |
| 136 | MAPKAPK2 | 0.52568043 |
| 137 | RPS6KA4 | 0.52498170 |
| 138 | CLK1 | 0.52387174 |
| 139 | BRD4 | 0.52054823 |
| 140 | HCK | 0.51420216 |
| 141 | AKT3 | 0.50408229 |
| 142 | MAP3K11 | 0.49702914 |
| 143 | SYK | 0.48945748 |
| 144 | IGF1R | 0.48413122 |
| 145 | ABL1 | 0.48273278 |
| 146 | CAMK2B | 0.47921364 |
| 147 | MAPK7 | 0.47116644 |
| 148 | MINK1 | 0.44019318 |
| 149 | CDK3 | 0.43599717 |
| 150 | CSNK1A1 | 0.43158382 |
| 151 | MAPK4 | 0.42659366 |
| 152 | BCR | 0.42477810 |
| 153 | STK3 | 0.42396868 |
| 154 | FRK | 0.42376238 |
| 155 | PDPK1 | 0.40772436 |
| 156 | PRKCE | 0.40509451 |
| 157 | STK4 | 0.40487045 |
| 158 | BMX | 0.40148989 |
| 159 | TTN | 0.40031734 |
| 160 | FYN | 0.39614894 |
| 161 | DYRK1A | 0.38956575 |
| 162 | PLK1 | 0.38464876 |
| 163 | EIF2AK2 | 0.37571969 |
| 164 | YES1 | 0.37504671 |
| 165 | CSNK1D | 0.37181218 |
| 166 | PRKACB | 0.36227176 |
| 167 | TSSK6 | 0.35560422 |
| 168 | UHMK1 | 0.34591001 |
| 169 | PTK2B | 0.34585965 |
| 170 | STK16 | 0.34434945 |
| 171 | PRKACA | 0.33188540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.51726167 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.55033143 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.24991048 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16060875 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12300802 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06286804 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00754666 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96234945 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95189691 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85628822 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82189461 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79299660 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78260528 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73688660 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69099077 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61111046 |
| 17 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58065151 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56973596 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53324328 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.48616573 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.48298579 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.48203160 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.47338980 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.47007330 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45994691 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.44065610 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42047810 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.39412915 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33743189 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.33415836 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33340649 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33333090 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.29422681 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.27073366 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25403242 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21898856 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20705066 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17338621 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15702445 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14656240 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14142255 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.12362089 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10912209 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.09129957 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08626883 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08258178 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07239835 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.04889810 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.03321373 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02181766 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01856059 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00220809 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99767004 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97543071 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96170441 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95394725 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95180467 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94420801 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94303899 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90200149 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89749187 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87552397 |
| 63 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85891807 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85792625 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83999926 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82828724 |
| 67 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.82244512 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82050394 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81668295 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81096838 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80987872 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80197934 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79747295 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77663451 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77464032 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77192117 |
| 77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76605204 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74569056 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71874325 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.71370834 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70798859 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70704918 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68326233 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67900306 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67773735 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67644422 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.67079275 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66534034 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.66149056 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.64829475 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.63060232 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62845690 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.61817789 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61517301 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60706879 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.60114842 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59847210 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59339540 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59034557 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58651777 |
| 101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58496887 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58169944 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57742524 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56898867 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56250034 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55690221 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.55268195 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55015502 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54976458 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54916320 |
| 111 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.54817259 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54715282 |
| 113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54618747 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53803829 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53403235 |
| 116 | Phototransduction_Homo sapiens_hsa04744 | 0.53196561 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51345183 |
| 118 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51186343 |
| 119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50055947 |
| 120 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49883107 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49781173 |
| 122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49642260 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48760735 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48546467 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48366452 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.48068295 |
| 127 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48061008 |
| 128 | Proteasome_Homo sapiens_hsa03050 | 0.47471117 |
| 129 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47320184 |
| 130 | Phagosome_Homo sapiens_hsa04145 | 0.47069915 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46558147 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46253784 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | 0.45941509 |
| 134 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45927830 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.43731304 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43725879 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42305377 |
| 138 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41329168 |
| 139 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40794021 |
| 140 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38777307 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35674622 |
| 142 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33240191 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33117319 |
| 144 | Tight junction_Homo sapiens_hsa04530 | 0.32135096 |
| 145 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31892741 |
| 146 | Adherens junction_Homo sapiens_hsa04520 | 0.31215603 |

